Alpine Immune Sciences Inc ALPN:NASDAQ

Last Price$8.05NASDAQ Closing Price as of 4:00PM ET 6/28/22

Today's Change-0.38(4.51%)
Bid (Size)$8.05 (8)
Ask (Size)$8.09 (3)
Day Low / High$7.93 - 8.56
Volume34.1 K
  • Latest Stories
  • Commentary and Analysis
Alpine Immune Sciences Says US FDA Lifts Partial Hold on Clinical Trial of Davoceticept Combined With Pembrolizumab
9:03AM ET 5/24/2022 MT Newswires

Alpine Immune Sciences (ALPN) said Tuesday that the US Food and Drug Administration has lifted the partial clinical hold placed on its NEON-2 clinical...

-- Earnings Flash (ALPN) ALPINE IMMUNE SCIENCES Posts Q1 Revenue $13.6M
4:27PM ET 5/12/2022 MT Newswires

...

Alpine Immune Q4 Loss Widens Amid Lower Revenue; Sees Enough Funds Through 2024
5:11PM ET 3/17/2022 MT Newswires

Alpine Immune Sciences (ALPN) on Thursday widened its net loss to $0.52 per share in Q4 from $0.27 per share a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (ALPN) ALPINE IMMUNE SCIENCES Posts Q4 Revenue $4.5M
4:05PM ET 3/17/2022 MT Newswires

...

Alpine Says FDA Places Partial Clinical Hold on Study of Davoceticept Drug Cocktail in Advanced Malignancies
9:48AM ET 3/07/2022 MT Newswires

Alpine Immune Sciences (ALPN) said Monday the US Food and Drug Administration placed its clinical study of davoceticept in combination with pembrolizumab...

Horizon Therapeutics Working With Alpine Immune Sciences to Develop Therapies for Autoimmune, Inflammatory Diseases
9:02AM ET 12/16/2021 MT Newswires

Horizon Therapeutics (HZNP) and Alpine Immune Sciences (ALPN) on Thursday entered into an exclusive agreement to develop novel protein-based therapies for...

-- Earnings Flash (ALPN) ALPINE IMMUNE SCIENCES Reports Q3 Revenue $8.5M
4:13PM ET 11/10/2021 MT Newswires

...

Insider Buy: Alpine Immune Sciences
9:26AM ET 9/22/2021 MT Newswires

Peter A. Thompson, 10% Owner, Director, on September 17, 2021, executed a purchase for 1,010,637 shares in Alpine Immune Sciences (ALPN) for $9,499,988....

Insider Sell: Alpine Immune Sciences
5:24PM ET 9/21/2021 MT Newswires

Jay Venkatesan, 10% Owner, Director, on September 17, 2021, sold 400,000 shares in Alpine Immune Sciences (ALPN) for $3,760,000. Following the Form 4...

Insider Buy: Alpine Immune Sciences
5:24PM ET 9/21/2021 MT Newswires

Xiangmin Cui, 10% Owner, Director, on September 17, 2021, executed a purchase for 1,542,553 shares in Alpine Immune Sciences (ALPN) for $14,499,998....